Skip to content
Recall Observatory FDA recall evidence

Drug product

Lisinopril & Hydrochlorothiazide Tables, USP 20mg/12.5mg, packaged in a)100-count bottles and b) 5000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 India, a) NDC 68180-519-01, b) 68180-519-30

D-1052-2016

April 04, 2016

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 73848
Status
Terminated
Classification
Class III
Quantity
59,520 Bottles
Official record key
drug-enforcement:D-1052-2016

Official wording

Reason: CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.

Code information: Lot #: a) H303459, b) H303460, Exp 09/2016

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations